XML 44 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value Measurements (Tables)
3 Months Ended
Mar. 31, 2014
Fair Value Measurements [Abstract]  
Assets and liabilities measured at fair value on recurring basis
The following tables present our money market funds and auction rate securities and contingent consideration liability measured at fair value on a recurring basis as of the dates indicated, classified by valuation hierarchy:

 
 
  
Fair Value Measurements at March 31, 2014
 
 
Balance at
March 31, 2014
  
Quoted Prices in Active Markets for Identical Assets
(Level 1)
  
Significant Other Observable Inputs
(Level 2)
  
Significant Unobservable Inputs
(Level 3)
Assets:
 
  
  
  
Money market funds
 
$
85,373
  
$
85,373
  
$
-
  
$
-
Auction rate securities
  
2,208
   
-
   
-
   
2,208
Total Assets
 
$
87,581
  
$
85,373
  
$
-
  
$
2,208
 
               
Liability:
               
Contingent consideration
 
$
16,200
  
$
-
  
$
-
  
$
16,200
Total Liability
 
$
16,200
  
$
-
  
$
-
  
$
16,200

 
 
  
Fair Value Measurements at December 31, 2013
 
 
Balance at
December 31, 2013
  
Quoted Prices in Active Markets for Identical Assets
(Level 1)
  
Significant Other Observable Inputs
(Level 2)
  
Significant Unobservable Inputs
(Level 3)
Assets:
 
  
  
  
Money market funds
 
$
60,364
  
$
60,364
  
$
-
  
$
-
Auction rate securities
  
2,208
   
-
   
-
   
2,208
Total Assets
 
$
62,572
  
$
60,364
  
$
-
  
$
2,208
 
               
Liability:
               
Contingent consideration
 
$
15,700
  
$
-
  
$
-
  
$
15,700
Total Liability
 
$
15,700
  
$
-
  
$
-
  
$
15,700

Quantitative information for fair value measurement of Level 3
The following table presents quantitative information pertaining to the March 31, 2014 fair value measurement of the Level 3 inputs. The assumptions remained unchanged since December 31, 2013:

 
Fair Value as
of March 31,
2014
 
Fair Value as of December 31,
2013
 
Valuation Technique
Unobservable Input
 
Range
(Weighted Average)
 
 
 
 
 
 
Asset:
 
 
 
 
 
Auction rate securities
$
2,208
 
$
2,208
 
Discounted cash flow model
Redemption period
 
5 to 15 years
(6 years)
 
      
    
Discount rate
 
0.25% - 3.00% (1.55%)
Contingent consideration
liability:
      
 
 
  
Azedra commercialization
$
2,300
 
$
2,300
 
Probability adjusted discounted cash flow model
Probability of success
 
40%
 
      
    
Period of milestone expected achievement
 
2017
 
      
    
Discount rate
 
10%
 
      
 
 
  
1404 commercialization
$
2,100
 
$
2,000
 
Probability adjusted discounted cash flow model
Probability of success
 
31%
 
      
    
Period of milestone expected achievement
 
2018
 
      
    
Discount rate
 
10%
 
      
 
 
  
MIP-1095 commercialization
$
500
 
$
500
 
Probability adjusted discounted cash flow model
Probability of success
 
19%
 
      
    
Period of milestone expected achievement
 
2021
 
      
    
Discount rate
 
10%
 
      
 
 
  
Net sales targets
$
11,300
 
$
10,900
 
Monte-Carlo simulation
Probability of success
 
19% - 40%
(32.8%)
 
      
    
Period of milestone expected achievement
 
2018 - 2022
 
      
    
Discount rate
 
12.5%

Summary of activities in financial instruments with Level 3 inputs
For those financial instruments with significant Level 3 inputs, the following table summarizes the activities for the periods indicated:

 
 
Asset – Auction Rate Securities
Fair Value Measurements Using Significant
Unobservable Inputs
(Level 3)
For the Three Months Ended March 31,
 
Description
 
2014
  
2013
 
Balance at beginning of period
 
$
2,208
  
$
3,240
 
Transfers into Level 3
  
-
   
-
 
Total realized/unrealized gains (losses)
        
Included in net income (loss)
  
-
   
-
 
Included in comprehensive income (loss)
  
-
   
8
 
Settlements
  
-
   
(100
)
Balance at end of period
 
$
2,208
  
$
3,148
 
  Total amount of unrealized gains (losses) for the period included in other comprehensive loss attributable to the change in fair market value of related assets still held at the reporting date
 
$
-
  
$
-
 

 
 
Liability – Contingent Consideration
Fair Value Measurements Using Significant
Unobservable Inputs
(Level 3)
For the Three Months Ended March 31,
 
Description
 
2014
  
2013
 
Balance at beginning of period
 
$
15,700
  
$
-
 
Fair value of contingent consideration – acquisition of Molecular Insight
  
-
   
15,900
 
Fair value change to contingent consideration included in net loss
  
500
   
-
 
Balance at end of period
 
$
16,200
  
$
15,900
 
  Changes in unrealized gains or losses for the period included in earnings (or changes in net assets) for liabilities held at the end of the reporting period
 
$
500
  
$
-